Restructuring Expenses (Tables)

3 Months Ended

Mar. 31, 2017

Restructuring and Related Activities [Abstract]

Restructuring Expense

The following table summarizes the restructuring expense recorded in each reportable segment and income statement classification for the three months ended March 31, 2017. There were no restructuring-related expenses recorded during the three months ended March 31, 2016.

	Automation and Analytics		Medication Adherence		Corporate		Total
	(in thousands)
Cost of revenue	$	1,266	$	431	$	—	$	1,697
Research and development	1,006		62		—		1,068
Selling, general and administrative	480		103		417		1,000
Total	$	2,752	$	596	$	417	$	3,765